These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 1901536

  • 1. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV.
    Diagn Microbiol Infect Dis; 1991; 14(1):75-7. PubMed ID: 1901536
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
    Doern GV, Tubert TA.
    Diagn Microbiol Infect Dis; 1990; 13(4):349-52. PubMed ID: 2127558
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
    Barry AL, Fuchs PC, Pfaller MA.
    Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, Nicoletti G.
    Chemotherapy; 1992 Jan; 38(1):36-45. PubMed ID: 1618002
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A.
    Diagn Microbiol Infect Dis; 1991 Jan; 14(1):63-74. PubMed ID: 2013211
    [Abstract] [Full Text] [Related]

  • 11. In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
    Jones RN, Barry AL.
    Chemioterapia; 1988 Oct; 7(5):283-6. PubMed ID: 3147148
    [Abstract] [Full Text] [Related]

  • 12. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE, Slocombe B, White AR.
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of cefprozil (BMY 28100) and cefepime (BMY 28142) against Streptococcus pneumoniae, Branhamella catarrhalis, and Haemophilus influenzae, and provisional interpretive criteria for disk diffusion and dilution susceptibility tests with Haemophilus influenzae.
    Doern GV, Vautour R.
    Diagn Microbiol Infect Dis; 1992 Sep; 15(7):633-40. PubMed ID: 1424521
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial activity and spectrum of ceftibuten (7432-S, SCH 39720)--a review of United States and Canadian results.
    Jones RN.
    Diagn Microbiol Infect Dis; 1991 Sep; 14(1):37-43. PubMed ID: 2013209
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV, Brueggemann AB, Pierce G, Holley HP, Rauch A.
    Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
    Laurans G, Gaudio F, Ducroix JP, Orfila J.
    Pathol Biol (Paris); 1991 May; 39(5):391-5. PubMed ID: 1909016
    [Abstract] [Full Text] [Related]

  • 20. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
    Delmée M, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R.
    Acta Clin Belg; 1996 May; 51(4):237-43. PubMed ID: 8858889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.